Researchers may have found a new way to weaken glioblastoma’s defenses against treatment. Blocking a protein called SET prevented tumors from forming in preclinical models, while targeting related proteins made cancer cells more vulnerable to radiation. The strategy works by restoring activity of PP2A, an enzyme that glioblastoma cells appear to suppress. Human testing will be needed to determine whether the approach is safe and effective.
More in Research
Popular brain supplement linked to shorter lifespan in men
September 6, 2026
Scientists find breast cancer cells hiding behind protective “shields”
September 6, 2026
This lifestyle program improved cognition 55% more than basic health advice
September 6, 2026
Scientists discover a hidden problem with this popular sugar substitute
September 6, 2026
Indonesia’s most dangerous fires are burning underground
September 6, 2026
AI can now control fusion plasma faster than humans can react
September 6, 2026
Latest News
Hunter Biden Launching $LAPTOP Memecoin Amid Praise For Crypto
September 7, 2026
Audi’s new A2 E-tron is its most affordable and efficient EV yet
September 7, 2026
5 Standout Women’s Takeaways From Creative Arts Emmys Night 2
September 7, 2026
J.A. Bayona’s ‘Beyond Society’ Doc Revisits Survivors’ Lives After Andes Crash Rescue
September 7, 2026
Jason Statham’s ‘Mutiny’ Seeks New Audience On Streaming This Week After Stalling At Box Office
September 7, 2026
Oil Prices Near $100, Hit Multi-Week Highs On Fresh U.S.-Iran Tensions
September 7, 2026
Audi’s new A2 E-tron is its most affordable and efficient EV yet
September 7, 2026
5 Standout Women’s Takeaways From Creative Arts Emmys Night 2
September 7, 2026
J.A. Bayona’s ‘Beyond Society’ Doc Revisits Survivors’ Lives After Andes Crash Rescue
September 7, 2026
Jason Statham’s ‘Mutiny’ Seeks New Audience On Streaming This Week After Stalling At Box Office
September 7, 2026
Oil Prices Near $100, Hit Multi-Week Highs On Fresh U.S.-Iran Tensions
September 7, 2026